Orphan
Developing drugs for rare diseases, once a rare phenomenon itself, has now become a standard strategy for many companies’ drug development pipelines
Med Tech
Bringing medical technology products to market is typically a time-consuming task. The journey involves navigating two distinct phases: pre-approval and post-approval
Market Access
This involves engaging with a diverse set of stakeholders, most prominently payers, who play a crucial role in determining which drugs make it to the market
Competitive Intelligence
Competitive intelligence serves as a key tool for pharmaceutical companies, providing valuable insights into their market, competitors, and customers, thereby enabling more effective decision-making
Medical Affairs
Medical affairs team gathers insights from essential stakeholders such as patients, HCPs, and payers, covering aspects of the patient journey, treatment landscape, products, and regulatory and reimbursement considerations
HEOR
HEOR assists healthcare decision-makers, including clinicians, governments, payers, health authorities, and patients, among others, in comparing the benefits and costs of available interventions and selecting from among these options
Forecasting
Pharmaceutical forecasting takes into account a multitude of market factors, such as patient access, clinical development, competitor activity, payer dynamics, product launch timings, product life cycle stage, RoA and dosage, promotions, and pricing strategy
Primary Market Research
PMR involves gathering data directly from target audiences, such as healthcare professionals, patients, payers, and other stakeholders. This research aims to understand their preferences, needs, behaviors, and perceptions regarding the products and services
Data Analytics
Systematically analyzing extensive datasets, including clinical trials, real-world evidence, patient records, and market data, to extract valuable insights is a complex task. It involves leveraging advanced statistical techniques and data visualization tools
